Skip to main content
S 3489 117th Congress Senate Health Chemical and biological weapons Department of Health and Human Services Drug therapy Emergency medical services and trauma care Hazardous wastes and toxic substances Health programs administration and funding Health promotion and preventive care Health technology, devices, supplies Home and outpatient care Infectious and parasitic diseases Medical research Medical tests and diagnostic methods National Institutes of Health (NIH) Nuclear weapons Product development and innovation Research administration and funding Research and development Scientific communication

A bill to establish or continue a multidisciplinary research program to advance the discovery and preclinical development of medical products for priority virus families and other viral pathogens…

Show full title

A bill to establish or continue a multidisciplinary research program to advance the discovery and preclinical development of medical products for priority virus families and other viral pathogens with a significant potential to cause a pandemic, and for other purposes.

Introduced: January 12, 2022 See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 117th Congress ended
It never became law before the 117th Congress (2021–2022) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 12, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Jan 12, 2022
Introduced in Senate
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

This bill directs the National Institutes of Health (NIH) to support research on medical products for virus families and viral pathogens with pandemic potential.

Specifically, the NIH must establish or continue a multidisciplinary program for supporting research centers to advance the discovery and development of medical products to prevent, treat, and diagnose such viruses.

What's happening now January 12, 2022

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 1
 Cosponsors 1
All 1 Democratic 1
D
Hickenlooper, John W.
Colorado · Jan 12, 2022
Cite this page click to expand
APA
U.S. Congress. (2026). S. 3489: A bill to establish or continue a multidisciplinary research program to advance the discovery and preclinical development of medical products for priority virus families and other viral pathogens with a significant potential to cause a pandemic, and for other purposes.. 117th Congress. Open America. https://openamerica.io/bill/117-S-3489/
MLA
"S. 3489: A bill to establish or continue a multidisciplinary research program to advance the discovery and preclinical development of medical products for priority virus families and other viral pathogens with a significant potential to cause a pandemic, and for other purposes.." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-S-3489/.
Bluebook (legal)
S. 3489, 117th Cong. (2026), https://openamerica.io/bill/117-S-3489/.
Markdown link
[S. 3489: A bill to establish or continue a multidisciplinary research program to advance the discovery and preclinical development of medical products for priority virus families and other viral pathogens with a significant potential to cause a pandemic, and for other purposes.](https://openamerica.io/bill/117-S-3489/)
Report a problem